BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33275730)

  • 1. Neuropathic pain in sickle cell disease: measurement and management.
    Glaros A; Brandow AM
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):553-561. PubMed ID: 33275730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathic Pain and Sickle Cell Disease: a Review of Pharmacologic Management.
    Orhurhu MS; Chu R; Claus L; Roberts J; Salisu B; Urits I; Orhurhu E; Viswanath O; Kaye AD; Kaye AJ; Orhurhu V
    Curr Pain Headache Rep; 2020 Jul; 24(9):52. PubMed ID: 32705357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathic pain in individuals with sickle cell disease.
    Sharma D; Brandow AM
    Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature.
    Brandow AM; Farley RA; Panepinto JA
    Pediatr Blood Cancer; 2015 Sep; 62(9):1501-11. PubMed ID: 25976161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the management of chronic pain in sickle cell disease.
    Osunkwo I; O'Connor HF; Saah E
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):562-569. PubMed ID: 33275672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Pain: Prevalence and Management.
    Carroll CP; Brandow AM
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1151-1165. PubMed ID: 36400536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
    Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review.
    Tolu SS; Van Doren L
    Transfus Apher Sci; 2022 Oct; 61(5):103533. PubMed ID: 36058780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How sickle cell disease patients experience, understand and explain their pain: An Interpretative Phenomenological Analysis study.
    Coleman B; Ellis-Caird H; McGowan J; Benjamin MJ
    Br J Health Psychol; 2016 Feb; 21(1):190-203. PubMed ID: 26333530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.
    Fiocchi J; Urits I; Orhurhu V; Orhurhu MS; Giacomazzi S; Hoyt B; Kaye AD; Kaye RJ; Viswanath O
    Curr Pain Headache Rep; 2020 Mar; 24(5):17. PubMed ID: 32200490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathic pain in patients with sickle cell disease.
    Brandow AM; Farley RA; Panepinto JA
    Pediatr Blood Cancer; 2014 Mar; 61(3):512-7. PubMed ID: 24167104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle Cell Disease: A Review of Nonpharmacological Approaches for Pain.
    Williams H; Tanabe P
    J Pain Symptom Manage; 2016 Feb; 51(2):163-77. PubMed ID: 26596876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiological mechanisms of pain in sickle cell disease.
    Wang ZJ; Wilkie DJ; Molokie R
    Hematology Am Soc Hematol Educ Program; 2010; 2010():403-8. PubMed ID: 21239826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A telephonic mindfulness-based intervention for persons with sickle cell disease: study protocol for a randomized controlled trial.
    Williams H; Silva S; Simmons LA; Tanabe P
    Trials; 2017 May; 18(1):218. PubMed ID: 28506281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease.
    Matthie N; Ross D; Sinha C; Khemani K; Bakshi N; Krishnamurti L
    J Natl Med Assoc; 2019 Apr; 111(2):158-168. PubMed ID: 30266214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathic Pain Screening: Construct Validity in Patients With Sickle Cell Disease.
    Powell-Roach K; Yao Y; Ezenwa MO; Schlaeger JM; Suarez ML; Molokie RE; Wang ZJ; Wilkie DJ
    West J Nurs Res; 2020 Feb; 42(2):125-130. PubMed ID: 30900520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review/overview of pain in sickle cell disease.
    Ballas SK; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102327. PubMed ID: 32147066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and emerging treatments for vaso-occlusive pain in sickle cell disease.
    Dampier C
    Expert Rev Hematol; 2019 Oct; 12(10):857-872. PubMed ID: 31364883
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for neuropathic pain in patients with sickle cell disease: is a single assessment scale sufficient?
    Antunes FD; Silva Junior CL; Cerqueira KS; do Livramento Faro M; Cipolotti R
    Orphanet J Rare Dis; 2019 May; 14(1):108. PubMed ID: 31088489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain.
    Dampier C; Palermo TM; Darbari DS; Hassell K; Smith W; Zempsky W
    J Pain; 2017 May; 18(5):490-498. PubMed ID: 28065813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.